Croda International Plc

LSE:CRDA Stock Report

Market Cap: UK£4.3b

Croda International Management

Management criteria checks 3/4

Croda International's CEO is Steve Foots, appointed in Jan 2012, has a tenure of 14.33 years. total yearly compensation is £1.78M, comprised of 44.3% salary and 55.7% bonuses, including company stock and options. directly owns 0.16% of the company’s shares, worth £6.75M. The average tenure of the management team and the board of directors is 6.8 years and 3.7 years respectively.

Key information

Steve Foots

Chief executive officer

UK£1.8m

Total compensation

CEO salary percentage44.30%
CEO tenure14.3yrs
CEO ownership0.2%
Management average tenure6.8yrs
Board average tenure3.7yrs

Recent management updates

Recent updates

Narrative Update May 17

CRDA: Mixed Broker Upgrades And Execution Risks Will Shape Future P/E Expectations

Analysts have adjusted their price targets on Croda International to around £32.80. This reflects updated assumptions on revenue growth, profit margins and future P/E multiples following a series of recent rating upgrades and target tweaks across the Street.
Narrative Update May 01

CRDA: Cluster Of Recent Upgrades Will Support Re Rating Potential

The updated analysis trims Croda International's fair value estimate slightly to £47.67 from £47.96, as analysts factor in recent target changes and upgrades that reflect adjusted assumptions for revenue growth, profit margins, and future P/E multiples. Analyst Commentary Recent Street research on Croda International has leaned constructive, with several bullish analysts adjusting ratings and targets in quick succession.
Narrative Update Apr 17

CRDA: Mixed Broker Upgrades And Execution Risks Will Shape Fair Value Outlook

Analysts have raised their fair value estimate for Croda International from £23.00 to £28.65, citing recent upgrades, higher price targets, and updated assumptions for revenue growth, profit margins, and future P/E multiples. Analyst Commentary Recent Street research on Croda International shows a mix of supportive and cautious views, with several firms revisiting their ratings and price targets in quick succession.
Narrative Update Apr 02

CRDA: Recent Upgrades And Higher 3,280 Price Level Will Support Re Rating

Analysts have nudged their fair value estimate for Croda International slightly lower to about £47.96 from £48.16, reflecting modest adjustments to discount rate, revenue growth, profit margin and future P/E assumptions, alongside mixed but generally constructive recent research, including both target cuts and upgrades. Analyst Commentary Recent Street research on Croda International has leaned constructive, with several bullish analysts updating their views through rating changes and revised price targets.
Narrative Update Mar 19

CRDA: Higher Price Move To 3,280 And Modest P/E Reset Signal Upside

Narrative Update The analyst price target for Croda International has been raised to £3,280, an increase of £250. Analysts reference recent target moves from major banks, along with small adjustments to revenue growth, profit margin, discount rate and future P/E assumptions.
Narrative Update Mar 05

CRDA: Higher Price References And Modest P/E Reset Will Support Upside Potential

Narrative Update The analyst price target for Croda International has been raised. Our fair value estimate has moved slightly higher to reflect recent increases in Street targets to around £32 per share, supported by analysts pointing to updated assumptions on discount rates, revenue growth, profit margins and future P/E expectations.
Narrative Update Feb 19

CRDA: Higher Fair Value Assumptions Will Drive Reappraisal Of Margin Resilience

Analysts have raised their price target on Croda International by £4.00. This reflects updated assumptions for fair value, discount rate, revenue growth, profit margins, and future P/E following recent research updates.
Narrative Update Feb 05

CRDA: Refined Assumptions And Lower P/E Will Support Higher Share Price

Analysts have trimmed their price target for Croda International by a small amount, reflecting updated views on fair value, discount rate, revenue growth, profit margin and future P/E assumptions. Valuation Changes Fair Value: trimmed slightly from £48.67 to £48.04 per share.
Narrative Update Jan 21

CRDA: Activist Pressure Will Drive Reappraisal Of Margin Resilience And Future Re Rating

Analysts have trimmed their price target for Croda International to £34.02 from £34.46, reflecting slightly more cautious assumptions on revenue growth and profit margin, along with a modestly higher discount rate and a higher future P/E multiple. Valuation Changes Fair Value Estimate: trimmed slightly to £34.02 from £34.46.
Analysis Article Jan 21

Is There An Opportunity With Croda International Plc's (LON:CRDA) 26% Undervaluation?

Key Insights Croda International's estimated fair value is UK£35.97 based on 2 Stage Free Cash Flow to Equity Current...
Narrative Update Jan 06

CRDA: Refreshed Q4 Guidance And Earnings Outlook Will Support Higher Share Price

Croda International's updated analyst price target has moved slightly higher, with recent revisions in the range of £30.50 to £33.00 per share, supported by analysts' refreshed assumptions for fair value, discount rate, revenue growth, profit margin and future P/E. Analyst Commentary Recent research shows a cluster of modestly higher fair value views for Croda International, with price targets in a relatively tight range of £30.50 to £33.00 per share.
Analysis Article Jan 06

Croda International Plc's (LON:CRDA) Popularity With Investors Is Clear

With a price-to-earnings (or "P/E") ratio of 27.2x Croda International Plc ( LON:CRDA ) may be sending very bearish...
Narrative Update Dec 17

CRDA: Activist Pressure Will Drive Future Reappraisal Of Margin Resilience

The analyst price target for Croda International has edged higher to approximately £31.00. This reflects modest improvements in forecast growth and valuation multiples as analysts point to stabilizing end markets and potential upside from strategic and activist driven initiatives, despite mixed target revisions across the Street.
Analysis Article Dec 05

Should You Investigate Croda International Plc (LON:CRDA) At UK£26.70?

Croda International Plc ( LON:CRDA ), is not the largest company out there, but it received a lot of attention from a...
Narrative Update Dec 03

CRDA: Activist Pressure Will Drive A Reappraisal Of Margin Resilience

Analysts have nudged up their price target on Croda International by about £1, placing it in the low £30s per share. They point to a stabilizing outlook, reflected in modestly higher Street targets and expectations that prior commoditization concerns may have been overstated.
Analysis Article Nov 20

Is Croda International (LON:CRDA) Using Too Much Debt?

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
Narrative Update Nov 18

CRDA: Activist Pressure And Commoditization Concerns Will Shape The Next Share Move

Croda International's analyst price target has seen a modest upward revision to 3,150 GBp from 3,000 GBp. This reflects analysts' view that recent sector updates and firm-specific catalysts support a slightly higher fair value for the shares. Analyst Commentary Recent research updates on Croda International have highlighted a mix of optimism and caution.
Narrative Update Nov 03

CRDA: Activist Pressure And Sector Outlook Will Drive Share Performance This Year

Croda International's analyst price target has been modestly raised, with the new consensus target increasing to approximately £31.00 from £30.00. Analysts cite slight improvements in revenue growth expectations and a lower discount rate as reasons for the update.
Narrative Update Oct 20

Sustainable Bio-Based Chemicals Will Expand In Asia And Latin America

Croda International's analyst consensus price target has seen a modest uptick, rising by £0.50 to £31.00. Analysts cite improved profit margins as offsetting softer revenue growth expectations.
Analysis Article Oct 06

Croda International (LON:CRDA) Will Be Hoping To Turn Its Returns On Capital Around

To find a multi-bagger stock, what are the underlying trends we should look for in a business? In a perfect world, we'd...
Narrative Update Oct 03

Sustainable Bio-Based Chemicals Will Expand In Asia And Latin America

Analysts have revised Croda International's price target downward from £36.00 to £31.00, citing shifts in fair value and an improving revenue growth outlook. Ongoing activist pressures are seen as a potential positive for shares despite persistent margin concerns.
Analysis Article Sep 18

Croda International Plc's (LON:CRDA) P/E Is On The Mark

With a price-to-earnings (or "P/E") ratio of 25.7x Croda International Plc ( LON:CRDA ) may be sending very bearish...
Narrative Update Sep 14

Sustainable Bio-Based Chemicals Will Expand In Asia And Latin America

Croda International’s consensus price target saw a modest reduction to £35.23 as both future P/E and revenue growth expectations remained stable. What's in the News Croda International is prioritizing organic investment with a focus on higher returns, risk management, and faster cash payback, while reducing CapEx as a percentage of sales from 2026 onwards.
Analysis Article Aug 15

Here's Why Croda International (LON:CRDA) Can Manage Its Debt Responsibly

LSE:CRDA 1 Year Share Price vs Fair Value Explore Croda International's Fair Values from the Community and select yours...
Analysis Article Jul 12

Croda International Plc's (LON:CRDA) Intrinsic Value Is Potentially 35% Above Its Share Price

Key Insights Croda International's estimated fair value is UK£40.28 based on 2 Stage Free Cash Flow to Equity Croda...
User avatar
New Narrative Mar 02

Acquisition Of Solus Biotech And Asian Expansion Will Strengthen Future Outlook

Strengthening local relationships and strategic acquisitions, particularly in Asia, should drive revenue through higher prices and increased manufacturing capacity.

CEO Compensation Analysis

How has Steve Foots's remuneration changed compared to Croda International's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2025UK£2mUK£787k

UK£62m

Sep 30 2025n/an/a

UK£101m

Jun 30 2025n/an/a

UK£140m

Mar 31 2025n/an/a

UK£149m

Dec 31 2024UK£1mUK£767k

UK£159m

Sep 30 2024n/an/a

UK£161m

Jun 30 2024n/an/a

UK£163m

Mar 31 2024n/an/a

UK£167m

Dec 31 2023UK£1mUK£745k

UK£171m

Sep 30 2023n/an/a

UK£182m

Jun 30 2023n/an/a

UK£194m

Mar 31 2023n/an/a

UK£422m

Dec 31 2022UK£4mUK£716k

UK£649m

Sep 30 2022n/an/a

UK£680m

Jun 30 2022n/an/a

UK£711m

Mar 31 2022n/an/a

UK£516m

Dec 31 2021UK£4mUK£682k

UK£321m

Sep 30 2021n/an/a

UK£284m

Jun 30 2021n/an/a

UK£247m

Mar 31 2021n/an/a

UK£224m

Dec 31 2020UK£2mUK£676k

UK£202m

Sep 30 2020n/an/a

UK£204m

Jun 30 2020n/an/a

UK£207m

Mar 31 2020n/an/a

UK£216m

Dec 31 2019UK£2mUK£662k

UK£224m

Compensation vs Market: Steve's total compensation ($USD2.39M) is below average for companies of similar size in the UK market ($USD4.30M).

Compensation vs Earnings: Steve's compensation has increased by more than 20% whilst company earnings have fallen more than 20% in the past year.


CEO

Steve Foots (57 yo)

14.3yrs
Tenure
UK£1,775,868
Compensation

Mr. Stephen Edward Foots, also known as Steve, C.B.E., serves as Non-Executive Director at Tate & Lyle plc since July 24, 2025 and serves as its Independent Non-Executive Director since 2025. He serves as...


Leadership Team

NamePositionTenureCompensationOwnership
Stephen Foots
Group Chief Executive & Executive Director14.3yrsUK£1.78m0.16%
£ 6.7m
Stephen Oxley
CFO & Executive Director1.1yrsUK£1.75m0.0062%
£ 262.5k
David Bishop
Director of Investor Relationsno datano datano data
Thomas Brophy
Group General Counsel13.4yrsno data0.011%
£ 468.5k
Anthony Fitzpatrick
President of Strategy12.1yrsno data0.014%
£ 599.1k
Michelle Lydon
President of Human Resources3.2yrsno datano data
Sandra Elaine Breene
President of Consumer Care10.3yrsno data0%
£ 0
Philip Ruxton
Chief Sustainability Officerno datano datano data
Thomas Riemeier
President of Life Sciences1.1yrsno datano data
Thiru Selvan
President of Supply Chain Operationsless than a yearno datano data
6.8yrs
Average Tenure
53.5yo
Average Age

Experienced Management: CRDA's management team is seasoned and experienced (6.8 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Stephen Foots
Group Chief Executive & Executive Director15.8yrsUK£1.78m0.16%
£ 6.7m
Stephen Oxley
CFO & Executive Director1.1yrsUK£1.75m0.0062%
£ 262.5k
Danuta Gray
Independent Non-Executive Chair of the Board2.3yrsUK£449.59k0.0037%
£ 157.9k
Keith Layden
Non-Executive Director9yrsUK£74.45k0.043%
£ 1.8m
Ian Bull
Independent Non-Executive Director1.9yrsUK£95.82k0.0025%
£ 106.4k
Roberto Cirillo
Independent Non-Executive Director8.1yrsUK£78.52kno data
Christopher Good
Independent Non-Executive Director3.1yrsUK£100.51k0.00071%
£ 30.2k
Jacqueline Patricia Ferguson
Senior Independent Director7.7yrsUK£108.76k0.00045%
£ 19.1k
Nawal Ouzren
Independent Non-Executive Director4.3yrsUK£78.74kno data
Jill Anderson
Independent Non-Executive Directorless than a yearno datano data
3.7yrs
Average Tenure
59yo
Average Age

Experienced Board: CRDA's board of directors are considered experienced (3.7 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/05/31 07:07
End of Day Share Price 2026/05/29 00:00
Earnings2025/12/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Croda International Plc is covered by 33 analysts. 13 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
James KnightBarclays
Katie RichardsBarclays
Amy LianBarclays